AssetMark Inc’s Astrana Health ASTH Stock Holding History

AssetMark Inc’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2	Closed	-$81	–	2374
2024 Q2	$81	Hold	2	–	–	﹤0.01%	2046
2024 Q1	$84	Buy	+2	New	+$78	﹤0.01%	1825

Other funds holding ASTH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

AssetMark Inc's ASTH Position: Q3 2024 in Review

AssetMark Inc sold out of Astrana Health (ASTH) in Q3 2024, closing a stake of 2 shares — an estimated $81 sold.

AssetMark Inc first reported a position in ASTH in Q1 2024 and held it in 2 quarters. The position peaked at $84 in Q1 2024. 189 funds tracked by Wall St. Rank hold ASTH as of Q3 2024.

AssetMark Inc reported no remaining Astrana Health position as of Q3 2024 after selling out during the quarter.
AssetMark Inc sold 2 Astrana Health shares in Q3 2024, an estimated $81.
AssetMark Inc first reported a position in Astrana Health in Q1 2024 and held it in 2 quarters.
AssetMark Inc's Astrana Health position peaked at $84 in Q1 2024.
189 funds tracked by Wall St. Rank held Astrana Health as of Q3 2024.

Based on AssetMark Inc's 13F filing for Q3 2024, filed 1 Nov 2024.